On June 21, 2023, Nevan Elam notified the Peak Bio, Inc. of his resignation from the Companyâs Board of Directors (the âBoardâ), effective immediately. Mr. Elamâs decision to resign from the Board is solely for personal reasons and is not the result of any disagreement with the Company with respect to any matter relating to the Companyâs operations, policies or practices, or any disagreements in respect of accounting principles, financial statement disclosure, or any issue impacting the Audit Committee of the Board (the committee on which he served and chaired).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | -.--% | -.--% | -95.41% |
Mar. 05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
Feb. 16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-95.41% | 199K | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Peak Bio, Inc. Announces Resignation of Nevan Elam from Board of Directors